This session will explore the latest epidemiological data on HIV prevalence among aging populations. It aims to identify trends and risk factors that contribute to the intersection of aging and HIV.

This track will discuss innovative geriatric care models specifically designed for HIV-positive individuals. Emphasis will be placed on interdisciplinary approaches to enhance patient outcomes.

This session will focus on the unique clinical management challenges faced by older adults living with HIV. Topics will include comorbidities, polypharmacy, and tailored treatment strategies.

This track will highlight recent advancements in antiretroviral therapy and their implications for older adults. Discussions will include efficacy, safety, and adherence in geriatric patients.

This session will examine the factors influencing medication adherence among aging populations with HIV. Strategies to improve adherence and patient engagement will be critically analyzed.

This track will focus on the translation of laboratory findings into clinical practice for aging populations living with HIV. It will explore the challenges and opportunities in bridging research and application.

This session will showcase innovative practices and technologies that enhance HIV care for older adults. Participants will discuss the potential impact of these innovations on patient quality of life.

This track will address public health initiatives aimed at improving outcomes for aging populations affected by HIV. It will explore community-based interventions and policy implications.

This session will delve into therapeutic strategies addressing the comorbidities commonly found in older adults with HIV. The focus will be on integrated care approaches and management protocols.

This track will explore the psychosocial challenges faced by older adults living with HIV. Discussions will include mental health, stigma, and support systems that facilitate better health outcomes.

This session will highlight emerging research directions in the field of HIV and aging. Participants will discuss the implications of new findings for clinical practice and policy development.